This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Paris Est Creteil Val De Marne. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017
Title: Christophe Morin: Innovator in Neurodegenerative Disease Research
Introduction
Christophe Morin is a notable inventor based in Saint Maur des Fosses, France. He has made significant contributions to the field of neurodegenerative diseases, particularly through his innovative patent related to Parkinson's disease. His work has implications for drug development and screening processes.
Latest Patents
Morin holds a patent titled "Chemical model of a neurodegenerative disease, method for preparation and uses of same." This invention focuses on the use of pyridinium furosemide and its derivatives in creating a chemical model for neurodegenerative diseases, specifically Parkinson's disease. The patent outlines methods for preparation and potential applications in identifying drug candidates through screening tests.
Career Highlights
Throughout his career, Christophe Morin has been associated with prestigious institutions such as the Centre National de la Recherche Scientifique and the Université Paris Est Créteil Val de Marne. His work in these organizations has allowed him to advance research in neurodegenerative diseases and contribute to scientific knowledge in this critical area.
Collaborations
Morin has collaborated with notable colleagues, including Thierry Martens and Michaël Rivard. These partnerships have likely enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Christophe Morin's innovative contributions to the understanding and modeling of neurodegenerative diseases highlight his role as a key inventor in this field. His patent and collaborations reflect a commitment to advancing medical research and improving drug development processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile